Osaic Holdings
DMRA

Osaic Holdings’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Osaic Holdings’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$1K – 7448
2021
Q3 		$1K Hold
16
– – ﹤0.01% 7015
2021
Q2 		$2K Buy
+16
New +$2.18K ﹤0.01% 6700

Other funds holding DMRA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Osaic Holdings's DMRA Position: Q4 2021 in Review

Osaic Holdings sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q4 2021, closing a stake of 16 shares — an estimated $1K sold.

Osaic Holdings first reported a position in DMRA in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2021. 25 funds tracked by Wall St. Rank hold DMRA as of Q4 2021.

  • Osaic Holdings reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Osaic Holdings sold 16 Damora Therapeutics, Inc. Ordinary Shares shares in Q4 2021, an estimated $1K.
  • Osaic Holdings first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q2 2021 and held it in 2 quarters.
  • Osaic Holdings's Damora Therapeutics, Inc. Ordinary Shares position peaked at $2K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.